The FDA on Thursday approved a transcranial direct current stimulation (tDCS) device as the first at-home non-drug therapy ...

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

The FL-100 tDCS system is available by prescription for adults with moderate to severe MDD in the current episode, either as monotherapy or as an adjunctive treatment.

The FDA has authorized Flow Neuroscience’s FL-100, the first fully remote at-home brain stimulation device for major ...

Flow Neuroscience’s at-home depression treatment device has become the first of its kind to be approved by the FDA.

Overall, Contreras underscored that combining predictive analytics, AI-driven modeling, and digital monitoring can help ...

Millions of Americans living with major depressive disorder struggle to find treatment options that work for them. Providers ...

Adding lumateperone (Caplyta; Johnson & Johnson) to ongoing antidepressant therapy (ADT) significantly improved depression severity in adults with major depressive disorder (MDD) who had not responded ...

Laughing gas (nitrous oxide) appears to offer rapid mood improvement for people with severe or treatment-resistant depression ...

Major depressive disorder (MDD), perhaps the most common form of depression (APA, 2013), has many subtypes, each with its unique characteristics and treatment needs. I was recently reviewing this with ...

Nitrous oxide may offer quick, short-term relief for people with major depression, especially those who haven’t responded to ...

The R&D pipeline for depression therapies faced a demoralizing 2025 as five high-profile candidates, including KOR ...